Ginkgo Bioworks Holdings (DNA)
Who owns Ginkgo Bioworks Holdings (DNA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 89.7% of the shares are freely tradable; institutional investors hold 68.7%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 5.58 | 3,642,347 | +1.9 | 03/31/2026 |
| Viking Global Investors LP | 5.48 | 3,577,128 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 4.44 | 2,900,952 | +17.0 | 12/31/2025 |
| Baillie Gifford & Co Limited. | 3.66 | 2,391,649 | +0.0 | 03/31/2026 |
| Erste Asset Management GmbH | 2.98 | 1,947,728 | -2.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.93 | 1,914,428 | +0.0 | 03/31/2026 |
| Anchorage Advisors, LLC | 2.67 | 1,746,363 | +0.0 | 03/31/2026 |
| Legal & General Group PLC | 2.54 | 1,661,587 | +5.3 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Scottish Mortgage Ord | 3.66 | 2,391,649 | +0.0 | 03/31/2026 |
| L&G Artificial Intelligence ETF | 2.56 | 1,669,027 | +0.5 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 17. Jul 2026 | Coen Steven P. | See remarks | Sell | 752 | 7.90 | 5,943 |
| 16. Jul 2026 | Coen Steven P. | See remarks | Other | 312 | – | – |
| 16. Jul 2026 | Coen Steven P. | See remarks | Other | 1,174 | – | – |
| 17. Apr 2026 | Steven P Coen | Insider | Sell | 324 | 7.95 | 2,576 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.